PRO1160

GEN1160 · Genmab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO1160, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) [Phase 1, Phase 2]